At present, big health has become a hot topic, and individuals should be the "first responsible person" for their own health, and health products provide a non-negligible boost for people's health. As an enterprise deeply engaged in the health and wellness industry, Infinitus has been continuously exploring the health field since its establishment 31 years ago, and has never stopped at in-depth research in the field under research. Recently, Infinitus published the latest "Human Food Trial of Hemp Seed Algae Oil Composition Assisted in Lowering Blood Lipids", which verified that hemp seed oil composition has the function of assisting in lowering blood lipids through human food trial experiments.
In this experiment, the samples were invited to take hemp seed algae oil composition for 90 days, and the data showed that the serum total cholesterol, triglycerides, and low-density lipoprotein cholesterol values of the trial group were lower than those before the trial and lower than those of the control group. According to the State Food and Drug Administration's Guo Shi Yao Jian Bao Hua [2012] No. 107 "Annex 6: Evaluation Method for Auxiliary Hypolipidemic Function", the test sample met the requirements of the positive result standard of human food test for auxiliary reduction of blood lipid function.
*It was shown that the hemp seed oil composition used in the human food tasting experiment contained -3 polyunsaturated fatty acids in each capsule. Among them, the intake of DHA+EPA contained in it is close to 250mg d, which helps to reduce the mortality and risk of coronary heart disease. The conclusion of the article showed that hemp seed algal oil composition was safe and well tolerated, and it was a healthy food that helped to maintain normal blood lipid levels.
In addition to the published articles, the scientific compounding technology of 4A polyunsaturated fatty acids of hemp seed algae oil composition has also been authorized by the United States invention patent (US10568919 B2).At the same time, after the evaluation of scientific and technological achievements in the food industry of Guangdong Province (Yue Shi Ping Zi [2021] No. 11), industry review experts unanimously agreed that the compound technology has reached the leading level in China.
Infinitus has been continuously increasing its investment in scientific research, building a unique scientific research system of "one center, supported by multiple scientific research and technology platforms", and committed to the development of independent characteristic products to continuously improve its core competitiveness. Located in Guangzhou Infinitus Plaza, the Infinitus Global R&D Center has a total construction area of 10,000 square meters and 79 laboratories, including 61 professional laboratories, with a value of more than 1100 million yuan of international advanced instruments and equipment.
In order to further enhance the forward-looking and advanced nature of scientific research, the Infinitus Global Scientific Advisory Committee, which is composed of Chinese and Western experts from different countries and regions around the world, combines the wisdom of traditional Chinese medicine with modern scientific and technological methods, and continues to provide professional advice and technical support to Infinitus in different areas of health needs.
From 2019 to 2022, Infinitus participated in the formulation and release of 5 national standards and 17 group standards, of which 3 were the leading unit of Infinitus.
Infinitus' continuous R&D investment, well-equipped and advanced laboratories, and multidisciplinary professionals have effectively guaranteed Infinitus' innovative scientific research capabilities. In the future, Infinitus will further strengthen its R&D capabilities, strengthen its leading position in the Chinese herbal health products industry, and provide more high-quality products and services for the public's healthy life.